Abbott Laboratories Price Today
Abbott Laboratories
ABT
Healthcare
$191.77B
💰
Market Cap
33.9
💸
Price to Earnings
$3.3
🎉
EPS
+75
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
14 |
Strong Buy |
8 |
Hold |
7 |
Sell |
0 |
Strong Sell |
0 |
ABT Price Forecast Target
110.5 👉 130.0 +18%
ABT EPS Forecast
3.3 👉 4.7 +44%
Financials
Profit Margin
14 %
Revenue Growth
1.5 %
Dividend
$ 2.2
Held Percent
0.5% - Insiders
77.0% - Institutions
22.5% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $17.3B
-
💰 Blackrock Inc. $14.8B
-
💰 Capital Research Global Investors $9.6B
-
💰 State Street Corporation $8.3B
-
💰 Capital International Investors $7.1B
Stock Ideas
Charlie Munger Portfolio
Charlie Munger, the renowned investor and Vice Chairman of Berkshire Hathaway, is a true titan in the world of finance. Often referred to as Warren Buffett's right-hand man, Munger's portfolio investment approach is a masterclass in disciplined and …
Daniel Sundheim Portfolio
Daniel Sundheim is the founder of D1 Capital Partners, a renowned multi-billion dollar global investment firm. Prior to starting his own firm, Sundheim worked as a portfolio manager at prestigious hedge funds before breaking out on his own in 2018. …
Bill Ackman Portfolio
Bill Ackman, a renowned investor, has established himself as a long-term value investor with a keen eye for short-term price fluctuations. His expertise lies in special situations investments, and his Pershing Square portfolio reflects a highly conc…
Jim Simons Portfolio
Jim Simons, the mastermind behind the Medallion Fund, has achieved such extraordinary returns that he has skyrocketed to the ranks of the world's wealthiest individuals. The secret to his success lies in the fund's implementation of high-frequency t…📮FAQ
Some Frequently Asked Questions.
The Abbott Laboratories industry is Medical Devices
The Abbott Laboratories sector is Healthcare
The Abbott Laboratories forecasted predicted Price to Earnings PE ratio is 23.5
The Abbott Laboratories Price to Earnings PE ratio is 33.9
The Market Capitalization of Abbott Laboratories is $191.77B
There are total of 1723870887 float shares with 77.0% held by Institutions and 0.5% held by insiders
The MAbbott Laboratories forecasted Earnings per Share EPS is $4.7
The Abbott Laboratories Earnings per Share EPS is 3.3
The Abbott Laboratories company has $0 gross profits with 14 profit margins
The Abbott Laboratories Earnings Growth is 0.55% with 0.543% quarterly earnings growth
The Abbott Laboratories Revenue is $40108998656 with 0.015 revenue growth
The price target for Abbott Laboratories stock is $130.0 for the high target and $98.6 for the low target
The consensus analyst recommendations for Abbott Laboratories is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Abbott Laboratories is Buy, with the following breakdown:
- Buy: 14
- Strong Buy: 8
- Hold: 7
- Sell: 0
- Strong Sell: 0
The Beta of Abbott Laboratories is 0.7
The dividend of Abbott Laboratories is $2.2
The dividend yield of Abbott Laboratories is 0.0199%
The biggest institutional and mutual fund holders of Abbott Laboratories stock are
- Vanguard Group Inc
- Blackrock Inc.
- Capital Research Global Investors
- State Street Corporation
The Abbott Laboratories ESG Score is 75, with the following breakdown:
- E: 2.27
- S: 14.24
- G: 8.33